With box warnings

Without box warnings

Branded

Generic

5 results

abiraterone
(Abiraterone acetate)
CivicaScript, LLC
Usage: Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).
abiraterone acetate
(abiraterone acetate)
Novugen Pharma (USA) LLC
Usage: Abiraterone acetate tablets are indicated, in combination with prednisone, for the treatment of metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).
erleada
(Apalutamide)
Janssen Products, LP
Usage: ERLEADA is indicated for treating metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC).
xtandi
(enzalutamide)
Astellas Pharma US, Inc.
Usage: XTANDI® is indicated for the treatment of patients with castration-resistant prostate cancer (CRPC), metastatic castration-sensitive prostate cancer (mCSPC), and non-metastatic castration-sensitive prostate cancer (nmCSPC) experiencing high-risk biochemical recurrence (high-risk BCR).
zytiga
(abiraterone acetate)
Janssen Biotech, Inc.
Usage: ZYTIGA is indicated for the treatment of metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC) when used in combination with prednisone.

Medications for Metastatic Castrationsensitive Prostate Carcinoma

abiraterone